Copy Link Print Information

Tidutamab

(別名: XmAb-18087)
カスタマーレビュー

Based on 1 Customer Validation

Tidutamab (XmAb-18087) is a humanized and affinity-optimized bispecific antibody (bsAb) targeting SSTR2 binding domain and T-cell binding domain (CD3). Tidutamab possesses a full Fc domain to maintain long serum half-life.Tidutamab eliminates SSTR+ tumor cells by stimulating redirected T cellmediated cytotoxicity (RTcC).

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

  • 純度: 96.71%
  • CAS 番号: 2148354-90-7
  • 分子量:150.74 kDa
  • 保管条件:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Tidutamab
  • Experimental Validation Results for Tidutamab
  • Experimental Validation Results for Tidutamab
  • Experimental Validation Results for Tidutamab
  • Tidutamab Chemical Structure
    Tidutamab 構造式
CAS 番号: 2148354-90-7
容量
価格（税別）
在庫状況
数量
Amount: USD 0.00
Please select quantity
or
or

* アイテムを追加する前、数量をご選択ください

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Tidutamab おすすめ製品:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
最寄りの代理店をお探しください Your local distributor: Hycultec GmbHHycultec
  • 生物活性
  • 化学情報
  • 純度とドキュメンテーション
  • 参考文献
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products
Keywords
MOQ
Minimum order quantity
100 mg

お問い合わせ 在庫あり

Other size
お問い合わせ
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress ログイン
Register
Sign in to MedChemExpress
新規会員登録

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    half-IGG1-kappa/(scFv-heavy-lambda)-h-CH2-CH3

  • 1/16

    Immobilized SSTR2 Protein-VLP, Human (HEK293, His, HY-P700430) can bind Tidutamab. The EC50 for this effect is 61.59 ng/mL.

  • 1/16

    Immobilized CD3 epsilon Protein, Human (HEK293, His, HY-P70506) can bind Tidutamab. The EC50 for this effect is 443.3 ng/mL.

  • 1/16

    Flow cytometric analysis of 1×106 Jurkat cells labelling CD3E (red) with Tidutamab (HY-P99562). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa Isotype Control (HY-P99001, blue) was used as the isotype control.

  • Tidutamab Chemical Structure
    1/16
  • Tidutamab
  • Immobilized SSTR2 Protein-VLP, Human (HEK293, His, HY-P700430) can bind Tidutamab. The EC50 for this effect is 61.59 ng/mL.
  • Immobilized CD3 epsilon Protein, Human (HEK293, His, HY-P70506) can bind Tidutamab. The EC50 for this effect is 443.3 ng/mL.
  • Flow cytometric analysis of 1×106 Jurkat cells labelling CD3E (red) with Tidutamab (HY-P99562). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa Isotype Control (HY-P99001, blue) was used as the isotype control.
  • half-IGG1-kappa/(scFv-heavy-lambda)-h-CH2-CH3